STOCK TITAN
  1. Home
  2. News
  3. CSBTF

KUROS BIOSCIENCE (CSBTF) Stock News, Oct 2023-Jan 2024

CSBTF OTC
News

Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
fda approval
-
News

Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.73%
Tags
clinical trial fda approval
-
News

Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.4%
Tags
clinical trial
News

Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.06%
Tags
fda approval
-
News

Kuros Reports a 150% Increase in Direct MagnetOs Sales in the First Nine Months of 2023 and Announces Changes Within the Executive Management

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of KUROS BIOSCIENCE (CSBTF)?

KUROS BIOSCIENCE (CSBTF) last closed at $24.

What is the market cap of KUROS BIOSCIENCE (CSBTF)?

The market cap of KUROS BIOSCIENCE (CSBTF) is approximately $926.2M.